Christoph Oing

Young Oncologists Committee member

Address The University of Manchester
Manchester Cancer Research Centre
Translational Oncogenomics Group
Manchester
Country

United Kingdom

oing-christoph

What is your current activity?

After finishing med school in 2010, I started my residency at the department of oncology, hematology and BMT at Hamburg University Medical Center where I finished specialty training in 2018. Currently, I am  a research fellow at the Manchester Cancer Research Centre based on a 2018 ESMO translational research fellowship.The project I am working on involves comprehensive genomic and transcriptomic analysis in the context of tumour hypoxia in prostate cancer. Concurrent clinical scientific projects of mine focus rare genitourinary malignancies, e.g. poor risk and refractory germ cell tumours and penile cancer.

As a member of the German Society of Hematology and Oncology (DGHO) and the German Testicular Cancer Study Group (GTCSG) I am actively participating in guideline development on diagnosis, treatment and follow-up of testicular cancer patients. Moreover, I recently founded the young oncologist working group as part of the DGHO to introduce my marvellous experiences from the ESMO YOC to our national society activities.

What motivates you?

Both, taking good care of patients as a perceptive and well-informed physician and personal efforts as a clinician scientist in the fight against cancer strongly motivate me.

Why did you choose to become a medical oncologist?

Malignant tumours are awful but biologically fascinating and the field of oncology is evolving breathtakingly fast. The close relationship between clinical care and translational research convinced me during my third year at med school, already and made me become a medical oncologist.

What does your involvement with ESMO and the Young Oncologists Committee (YOC) mean to you?

Personally, I feel honoured to be part of ESMO’s YOC and to participate in an international network of highly motivated, competent and ambitious colleagues to identify and address together the needs of young medical oncologists all over Europe. Moreover, to actively participate in various activities of ESMO, including the YO track at the ESMO annual meetings or the ESMO student courses is very stimulating and fun.

Do you have some good advice you would like to share with your international colleagues?

Whatever you are up to, clinical practice, clinical research, basic or translational science or a combination of all these aspects of oncology, networking is indispensable. Networking with young colleagues nationally and internationally is a great opportunity to widen your horizon and to realize personal career plans and projects successfully.